The terms of the agreement include a $50 million upfront payment, the potential for $385 million in success-based milestones and additional sales based milestones and royalties on sales.
The court ruled in SonoSite’s favor on five of the six patents that GE had asserted. The court ruled that one of GE’s patents is invalid and that
Tianyin’s simvastatin tablets are sold by prescription in hospitals, which is said to be the major sales channel for drugs in China. Tianyin will start producing simvastatin tablets
The trial will assess the safety, tolerability and pharmacokinetics of SGN-70 in healthy volunteers. The Phase I study is a dose-escalation trial in which cohorts of healthy volunteers
In connection with a decision made by DelSite’s board of directors, DelSite will exit the wound care business, including the manufacture of wound care products under the Carrington
The company has filed its abbreviated new drug application (ANDA) containing a paragraph IV certification for a generic Xyzal product with the FDA in January 2008. Following receipt
Lupin’s divalproex sodium delayed-release tablets are the AB-rated generic equivalent of Abbott Laboratories’s Depakote tablets, indicated for the treatment of certain types of seizures and convulsions. It may
The Phase I-II study is a multicenter, open-label study of the X-linked inhibitor of apoptosis antisense AEG35156 in patients with relapsed or refractory chronic lymphocytic leukemia (CLL), small
Intraoperative neurophysiological monitoring services (IONM) assesses neurological function involving the brain, spinal cord and related nerve structures during such surgeries. Acording to Impulse Monitoring, use of IONM facilitates
The units were priced at $0.70 per unit which at closing separated into a share of PolyMedix common stock and a five year warrant to purchase a share
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.